Epidemiology and Laboratory Capacity for Infectious Diseases (ELC)

 

The purpose of this program is to protect the public health and safety of the American people by enhancing the capacity of public health agencies to effectively detect, respond, prevent and control known and emerging (or re-emerging) infectious diseases. This is accomplished by providing financial and technical resources to: (1) strengthen epidemiologic capacity; (2) enhance laboratory capacity; (3) improve health information systems; and (4) enhance collaboration among epidemiology, laboratory, and information systems components of public health departments.

Active 93.323 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Not applicable. Public Health Service Act Sections 301(a)[42 U.S.C. 241(a)] and 317(k)(2)[42 U.S.C. 247b(k)(2)]
Prevention and Public Health Fund, Title Patient Protection and Affordable Care Act, Part 11-148, Section Title IV, Section 4002 Eligible applicants consist of state, local, and U.S. territory/possession governments previously funded. Specifically, these include: all 50 states, Washington, D.C., 5 largest local health departments (Chicago, Illinois; Houston, Texas; Los Angeles, California; New York City, New York; Philadelphia, Pennsylvania;), the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau or their bona fide agents. Direct beneficiaries include all 50 states, Washington, D.C., 5 largest local health departments (Chicago, Illinois; Houston, Texas; Los Angeles, California; New York City, New York; Philadelphia, Pennsylvania;), the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau or their bona fide agents. Not applicable. Preapplication coordination is required. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. 1. For the first year of the 5-year period of performance, the Notice of Funding Opportunity (NOFO) is published on Grants.gov. Recipients must complete an application and submit in Grants.gov by the posted deadline. 2. For years 2 through 5, also referred to as continuation funding years, the continuation guidance is published in GrantSolutions for ELC recipients to request financial assistance for the upcoming budget period. The deadline for application is posted in the guidance. 3. ELC recipients may also request additional funds to address emerging issues (e.g., outbreaks) by submitting a recipient-initiated request for supplemental funding at any time during the current budget period. Applications that are complete and responsive will be evaluated for scientific and technical merit and receive support. CDC will not review incomplete and non-responsive applications. Applications that are complete and responsive will undergo an objective/technical review process, receive a written critique and be scored according to the published review criteria. Successful applicants will receive a Notice of Award (NOA) from the CDC Office of Grants Services (OGS). The NOA shall be the only binding, authorizing document between the recipient and CDC. The NOA will be signed by an authorized OGS Grants Management Officer. Initial award provides funds for the first budget period (usually 12 months) and the NOA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, and special conditions, if any. Contact the headquarters or regional location, as appropriate for application deadlines From 90 to 120 days. Not applicable. From 90 to 120 days. Renewals of funding will be determined on recipient need, strength of application, and availability of funding. Applications will be evaluated based on: (1) strength of the proposed workplan that includes quantitative process and outcome measures; (2) adequate and clear information to enable the reviewer to gain a reasonable understanding of the applicant's recent and current efforts to address the issues; and (3) provide a realistic plan with activities that can be achieved in the budget period. Other criteria will be listed in the program and project sections within the funding opportunity announcement. Financial and technical resources are intended to be utilized for non-research activities that (1) strengthen epidemiologic capacity; (2) enhance laboratory capacity; (3) improve information systems; and (4) enhance collaboration among epidemiology, laboratory, and information systems components of public health departments. Activities may include those that enable a public health organization to establish and maintain a capable and qualified workforce, achieve modern and well-equipped public health laboratories, implement up-to-date health information systems, and institute systems that foster communication and appropriate integration across epidemiology, laboratory, and health information systems. Federal Financial Assistance (FA) and Direct Assistance (DA) are authorized. Performance Reports: Annual Federal Financial Reports (FFR) and performance/progress reports are required. Final FFRs and performance reports are required. Other reporting may be required and will be outlined in the NOFO or the Notice of Award. Not applicable. In accordance with 2 CFR ?200, as codified in 45 CFR ?75, there is a 3-year record retention requirement; records shall be retained beyond the 3-year period if final audit has not been done or findings resolved. Property records must be retained in accordance with HHS Grants Policy Statement requirements. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Financial assistance is provided for a 12-month budget period with project period up to five years subject to availability of funds and satisfactory continuation application from the recipient. Notice of Award None/Not specified. Jason Snow, PhD - ELC Director
Scientific Programs & Development Branch (SPDB)
Division of Preparedness and Emerging Infections (DPEI)
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Centers for Disease Control and Prevention (CDC)
1600 Clifton, Building 24, Office 11221
Mailstop H24-11
Atlanta, GA 30329
Atlanta, GA 30329 USA
itk0@cdc.gov
Phone: 4046394577 https://www.cdc.gov/elc 56-2721-1-1-101 (Cooperative Agreements) FY 22$1,518,838,904.00; FY 23 est $948,784,383.00; FY 24 est $250,000,000.00; FY 21$30,288,377,962.00; FY 20$11,222,896,748.00; FY 19$231,100,745.00; FY 18$217,226,427.00; FY 17$259,572,511.00; FY 16$197,654,769.00; - FY22, & FY23 obligations include COVID supplemental funding. Financial assistance under the ELC Cooperative Agreement is awarded through four (4) programs and twenty (20) projects. All program/project awards are based on recipient need, strength of application, and subject to availability of funds. While there are 64 ELC recipients, not all receive funding under all 24 programs and projects. Basic grant administration policies of DHHS and PHS are applicable, 45 CFR 75, HHS Grants Policy Statement Not applicable.